Abstract ISI
 (2022)

First-line Therapy with Nivolumab (NIVO) plus Ipilimumab (IPI)+2 Cycles of Chemotherapy (chemo) vs Chemotherapy alone (4 Cycles) in Patients (pts) with metastatic non-small cell Lung Cancer (mNSCLC): 3-year Update of CheckMate 9LA

Misch, D; Paz-Ares L.G.; Ciuleanu T.E.; Cobo-Dols, M; Bennouna J.; Cheng Y.; Mizutani, H; Lingua A.; Reyes F.; Reinmuth N.; Menezes J.; Jassem J.; Protsenko, S; Feeney K.; Jimenez D.E.; et. al.